Liver disease can cause published in the medical journal Australian repeated exposure to a widely used anesthetic after a case study.
The case has impact on the as required to short-term pain fast on short, painful procedure - Methoxyflurane - that is used, the researchers say.
Methoxyflurane is no longer in general anaesthesia due to their toxic effects on the liver, but the side effects are rare outbreaks of single dose paramedics transported.
Doctors examined a 33 year-old woman, the Royal Brisbane hospital for women with acute hepatitis, was taken four weeks after the start of a range of treatments for varicose veins.
You had no history of alcohol abuse, no risk for viral hepatitis and no family history of hepatitis or liver disease, Dr. Kacey Rourke, the doctor Registrar said.
In each of the three veins treatments, Methoxyflurane gave him however of an inhaler.
"It seems that it was the probable acute hepatitis Methoxyflurane in our patient exposure to, and it may be that a factor has been repeated exposure," Dr. O' said Rourke.
"This finding has implications for the nature and way Methoxyflurane is required, including the use of procedural analgesia in cases where multiple processes (and thus repeated doses) are required.".
The patient recovered and was recommended to prevent future exposure to Methoxyflurane.
Source
Medical Journal of Australia